OneSource Specialty [ONESOURCE] vs Blue Jet Healthcare [BLUEJET] Detailed Stock Comparison

OneSource Specialty
NSE
Loading...

Blue Jet Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: OneSource Specialty wins in 5 metrics, Blue Jet Healthcare wins in 12 metrics, with 0 ties. Blue Jet Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | OneSource Specialty | Blue Jet Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | -1,155.58 | 37.48 | OneSource Specialty |
Price-to-Book Ratio | 3.62 | 11.87 | OneSource Specialty |
Debt-to-Equity Ratio | 16.03 | 1.76 | Blue Jet Healthcare |
PEG Ratio | N/A | 0.27 | N/A |
EV/EBITDA | 33.16 | 26.50 | Blue Jet Healthcare |
Profit Margin (TTM) | -0.85% | 29.35% | Blue Jet Healthcare |
Operating Margin (TTM) | 6.32% | 32.50% | Blue Jet Healthcare |
EBITDA Margin (TTM) | 6.32% | 32.50% | Blue Jet Healthcare |
Return on Equity | -0.31% | 26.93% | Blue Jet Healthcare |
Return on Assets (TTM) | -0.24% | 21.53% | Blue Jet Healthcare |
Free Cash Flow (TTM) | $-1.96B | $-341.15M | Blue Jet Healthcare |
Dividend Yield | N/A | 0.11% | N/A |
1-Year Return | 10.15% | 50.68% | Blue Jet Healthcare |
Price-to-Sales Ratio (TTM) | 14.39 | 11.02 | Blue Jet Healthcare |
Enterprise Value | $179.27B | $131.52B | OneSource Specialty |
EV/Revenue Ratio | 12.11 | 10.76 | Blue Jet Healthcare |
Gross Profit Margin (TTM) | 71.61% | 48.44% | OneSource Specialty |
Revenue per Share (TTM) | $139 | $70 | OneSource Specialty |
Earnings per Share (Diluted) | $-1.12 | $20.70 | Blue Jet Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
OneSource Specialty vs Blue Jet Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
OneSource Specialty | -1.16% | 2.92% | -3.60% | 6.75% | 39.66% | 10.15% |
Blue Jet Healthcare | -3.96% | -5.70% | -6.67% | -9.15% | -7.65% | 27.56% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
OneSource Specialty | 10.15% | 10.15% | 10.15% | 10.15% | 10.15% | 10.15% |
Blue Jet Healthcare | 50.68% | 88.94% | 88.94% | 88.94% | 88.94% | 88.94% |
Performance & Financial Health Analysis: OneSource Specialty vs Blue Jet Healthcare
Metric | ONESOURCE | BLUEJET |
---|---|---|
Market Information | ||
Market Cap | ₹212.97B | ₹134.59B |
Market Cap Category | Large cap | Mid cap |
10 Day Avg. Volume | 112,761 | 356,828 |
90 Day Avg. Volume | 157,239 | 791,741 |
Last Close | ₹1,861.80 | ₹707.40 |
52 Week Range | ₹1,209.95 - ₹2,248.00 | ₹460.50 - ₹1,027.80 |
% from 52W High | -17.18% | -31.17% |
All-Time High | ₹2,248.00 (Jun 18, 2025) | ₹1,027.80 (Jul 21, 2025) |
% from All-Time High | -17.18% | -31.17% |
Growth Metrics | ||
Quarterly Revenue Growth | 3.18% | 1.18% |
Quarterly Earnings Growth | N/A | 1.41% |
Financial Health | ||
Profit Margin (TTM) | -0.01% | 0.29% |
Operating Margin (TTM) | 0.06% | 0.33% |
Return on Equity (TTM) | 0.00% | 0.27% |
Debt to Equity (MRQ) | 16.03 | 1.76 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹514.02 | ₹65.36 |
Cash per Share (MRQ) | ₹33.31 | ₹17.68 |
Operating Cash Flow (TTM) | ₹-2,152,760,000 | ₹899.31M |
Levered Free Cash Flow (TTM) | ₹-179,710,000 | ₹3.05B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.11% |
Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: OneSource Specialty vs Blue Jet Healthcare
Metric | ONESOURCE | BLUEJET |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -1,155.58 | 37.48 |
Forward P/E | 27.50 | 47.48 |
PEG Ratio | N/A | 0.27 |
Price to Sales (TTM) | 14.39 | 11.02 |
Price to Book (MRQ) | 3.62 | 11.87 |
Market Capitalization | ||
Market Capitalization | ₹212.97B | ₹134.59B |
Enterprise Value | ₹179.27B | ₹131.52B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 12.11 | 10.76 |
Enterprise to EBITDA | 33.16 | 26.50 |
Risk & Other Metrics | ||
Beta | N/A | N/A |
Book Value per Share (MRQ) | ₹514.02 | ₹65.36 |
Financial Statements Comparison: OneSource Specialty vs Blue Jet Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ONESOURCE | BLUEJET |
---|---|---|
Revenue/Sales | ₹3.27B | ₹3.40B |
Cost of Goods Sold | ₹929.19M | ₹1.53B |
Gross Profit | ₹2.34B | ₹1.87B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹206.81M | ₹1.35B |
EBITDA | ₹937.52M | ₹1.52B |
Pre-Tax Income | ₹-43.99M | ₹1.47B |
Income Tax | ₹-42.13M | ₹371.18M |
Net Income (Profit) | ₹-1.86M | ₹1.10B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ONESOURCE | BLUEJET |
---|---|---|
Cash & Equivalents | N/A | ₹329.79M |
Total Current Assets | N/A | ₹10.06B |
Total Current Liabilities | N/A | ₹2.56B |
Long-Term Debt | N/A | ₹165.26M |
Total Shareholders Equity | N/A | ₹11.33B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | N/A | ₹3.00B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ONESOURCE | BLUEJET |
---|---|---|
Operating Cash Flow | N/A | ₹539.01M |
Capital Expenditures | N/A | ₹-514.91M |
Free Cash Flow | N/A | ₹-54.59M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ONESOURCE | BLUEJET |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 112,761 | 356,828 |
Average Daily Volume (90 Day) | 157,239 | 791,741 |
Shares Outstanding | 114.44M | 173.47M |
Float Shares | 56.03M | 22.44M |
% Held by Insiders | 0.41% | 0.86% |
% Held by Institutions | 0.25% | 0.01% |
Dividend Analysis & Yield Comparison: OneSource Specialty vs Blue Jet Healthcare
Metric | ONESOURCE | BLUEJET |
---|---|---|
Last 12-Month Dividend | N/A | ₹1.00 |
Last 12-Month Dividend Yield | N/A | 0.11% |
3-Year Avg Annual Dividend | N/A | ₹0.33 |
3-Year Avg Dividend Yield | N/A | 0.19% |
3-Year Total Dividends | N/A | ₹1.00 |
Ex-Dividend Date | N/A | Sep 17, 2024 |